NZ200153A - Treating acne and oily skin by topically administering a composition sulphurated lime solution and a mixture of clays - Google Patents
Treating acne and oily skin by topically administering a composition sulphurated lime solution and a mixture of claysInfo
- Publication number
- NZ200153A NZ200153A NZ200153A NZ20015382A NZ200153A NZ 200153 A NZ200153 A NZ 200153A NZ 200153 A NZ200153 A NZ 200153A NZ 20015382 A NZ20015382 A NZ 20015382A NZ 200153 A NZ200153 A NZ 200153A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- attapulgite
- pungent
- kaolin
- bentonite
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 55
- 206010000496 acne Diseases 0.000 title description 19
- 208000002874 Acne Vulgaris Diseases 0.000 title description 17
- 206010039792 Seborrhoea Diseases 0.000 title description 7
- 230000037312 oily skin Effects 0.000 title description 7
- 235000008733 Citrus aurantifolia Nutrition 0.000 title 1
- 235000011941 Tilia x europaea Nutrition 0.000 title 1
- 239000004571 lime Substances 0.000 title 1
- JNVCSEDACVAATK-UHFFFAOYSA-L [Ca+2].[S-]SSS[S-] Chemical compound [Ca+2].[S-]SSS[S-] JNVCSEDACVAATK-UHFFFAOYSA-L 0.000 claims description 26
- 229940051851 sulfurated lime Drugs 0.000 claims description 26
- 229960000892 attapulgite Drugs 0.000 claims description 22
- 229910052625 palygorskite Inorganic materials 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 17
- 239000004927 clay Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000002594 sorbent Substances 0.000 claims description 10
- 239000005995 Aluminium silicate Substances 0.000 claims description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 9
- 235000012211 aluminium silicate Nutrition 0.000 claims description 9
- 239000000440 bentonite Substances 0.000 claims description 9
- 229910000278 bentonite Inorganic materials 0.000 claims description 9
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 9
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 9
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 239000004606 Fillers/Extenders Substances 0.000 claims description 5
- 239000000378 calcium silicate Substances 0.000 claims description 5
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 5
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 claims description 4
- 229910000271 hectorite Inorganic materials 0.000 claims description 4
- 239000000049 pigment Substances 0.000 claims description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 4
- 229930002330 retinoic acid Natural products 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- 229960001727 tretinoin Drugs 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 230000001877 deodorizing effect Effects 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
- 239000000454 talc Substances 0.000 claims description 3
- 229910052623 talc Inorganic materials 0.000 claims description 3
- 229940009868 aluminum magnesium silicate Drugs 0.000 claims description 2
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 2
- 229910052709 silver Inorganic materials 0.000 claims 2
- 239000004332 silver Substances 0.000 claims 2
- 238000005494 tarnishing Methods 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 235000010216 calcium carbonate Nutrition 0.000 claims 1
- 230000003292 diminished effect Effects 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 229960001755 resorcinol Drugs 0.000 claims 1
- 229910021647 smectite Inorganic materials 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 235000012222 talc Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 8
- 229940011871 estrogen Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- -1 aluminum silicates Chemical class 0.000 description 4
- 235000012216 bentonite Nutrition 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940127234 oral contraceptive Drugs 0.000 description 3
- 239000003539 oral contraceptive agent Substances 0.000 description 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000012050 conventional carrier Substances 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- 206010006313 Breast tenderness Diseases 0.000 description 1
- AGVJBLHVMNHENQ-UHFFFAOYSA-N Calcium sulfide Chemical class [S-2].[Ca+2] AGVJBLHVMNHENQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010058015 Infected cyst Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010064008 Vulvovaginal adenosis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000001135 feminizing effect Effects 0.000 description 1
- 201000000079 gynecomastia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 description 1
- 229960001390 mestranol Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008180 pharmaceutical surfactant Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 206010046885 vaginal cancer Diseases 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
New Zealand Paient Spedficaiion for Paient Number £00153
2 0 01 5 3
Priority Det-wi):
Comp!«t« Specification Filed: TV.1?." Cf5««
APR 1985
S|
Pubiicaticn Date:
P.O. tio: .. ......
Under the provisions of RegO^ latlon 23 (0 the
Specification has been ante-dated
IJLJ&&4ZC. 19 £L~
SAVINGS
NEW ZEALAND PATENTS ACT, J 953
No.. Divided out of No. 198 575 Dale; 7 October^ 19 81
COMPLETE SPECIFICATION
29MAR/9ffif|
11%
"METHOD AND COMPOSITION FOR TREATING ACNE"
fyWe, RORER INTERNATIONAL (OVERSEAS) INC., a Delaware Corporation, of 110 West Tenth Street, Wilmington, Delaware 19899, U.S.A.,
hereby declare the invention for which £ / we pray that a patent may be granted to ikk/us, and the method by which it is to be performed, to be particularly described in and by the following statement: -
(followed bv paqe la)
/
200153
This invention relates to.methods of topically treating acne and oily skin and compositions useful for said treatment. The invention also relates to a method for deodorizing compositions containing sulfurated lime solution which are intended for topical 5 administration, and for preventing stain of skin or fabric as well as discoloration of jewelry by the composition.
This is a divisional of New Zealand Patent Specification 198,575.
It is well established that acne is associated with sebum 10 production and that androgens stimulate sebum production whereas estrogens suppress sebum production; estrogen therapy being indicated as a possible means of treating acne. Several reports indicate that oral contraceptives or the individual active estrogenic components thereof, for example, ethinyl estradiol and 15 derivatives are useful in treating acne in both males and females.
r
In recent years it has become apparent that estrogenic products currently in use possess certain undesirable side effects which must be set against the undoubted benefits resulting from their use. The use of estrogens for the treatment of acne in women can 20 lead to uterine bleeding and spotting and breast tenderness. In men, estrogen administration can have a feminizing effect and may
— I« —
result in gynecomastia and impotence [L.F. Goodman and A.
Gilman, The Pharmacological Basis of Therapeutics, 4th ed. , The MacMillan Company, p.1537 (1970)]. Estrogenic therapy has
I
been reported to give rise' to other deleterious side effects. For example, diethylstilbestrol, a once widely used and well established estrogen has been implicated as possibly being responsible for vaginal cancer and adenosis in the female offspring of pregnant women treated with the compound (Lancet 1975, 1960). Also, ethinyl estradiol and mestranol, which represent estrogenic compounds in current oral contraceptives, are now known to be involved in certain serious side effects associated with oral contraceptives including depression [Nature 243, 58 (1973)], hypertension [Am. J. Obstet. Gynecol. 112, 912, (1972)], carbohydrate and lipid abnormalities (Lancet 1969, p.783), interference with blood .clotting mechanism resulting in thrombosis and stroke [Ann. Intern. Med. 72, 111, (1970)], and jaundice [Am. J. Obstet Gynecol. 119, 1965, (1974)]. Consequently, there is a need, for an improved method of treating acne.
It an cbject of this invention to ao sopo w.?y resting this need or at least to provide the public with a useful choice.
Accordingly the invention may be said broadly to consist, of a method for treating acne and oily skin in a patient in need thereof which comprises topically administering to said patient a composition comprising an effective amount of a sulfurated lime solution in a carrier comprising a pharmaceutically acceptable finely divided inorganic sorbent powder.
In another aspect the invention may be said broadly to consist in a method of treating oily skin in a patient in need thereof which comprises topically administering to said patient a composition comprising 1-10% by weight of a sulfurated lime solution and 5-50% by weight of a pharmaceutically acceptable clay or pigment extender.
- 20015,3
In yet another aspect the invention may be said broadly to consist of an anti-acne and anti-seborrheic pharmaceutical composition for topical administration comprising an effective amount of a sulfurated lime solution and 5-50% by weight of a carrier comprising a pharmaceutically acceptable clay, pigment extender or mixtures thereof.
As used herein the term "acne" is intended to mean any inflammatory disease or condition of the sebaceous gland commonly occurring at puberty resulting in comedones, pustules, papules, inflamed nodules or infected cysts. A solution of sulfurated lime in combination with a finely divided sorbent powder consisting of a mixture of clays, namely, a montmorillonite clay in combination with attapulgite, has been found to be effective in reducing the amount of sebum produced by sebaceous glands.
The composition of the present invention, when administered to a patient having an acne condition or oily skin condition,
t*5 3
represents a novel method of treating acne which offers distinct advantages over previously employed methods of treatment, for example, estrogen therapy, in that the compounds employed do not result in certain deleterious side effects resulting with estrogen therapy as will become more apparent hereinafter.
"Sulfurated lime" as used herein is commercially available and may be prepared according to the procedure,disclosed in Mellor, Vol. Ill, p. 740 (1928). Generally, sulfurated lime contains not less than 55% calcium sulfides and polysulfides and the balance being calcium sulfate, sulfides and carbonate, and the "ash" from the carbonaceous material from which it is formed.
It has been surprisingly discovered that the combination of1 a montmorillonite clay and attapulgite removes the odor of the sulfurated solution while releasing any perfume odor which may be present.
The clay which may be utilized in the composition of the
I
I
present invention are the natural and synthetic montmorillonite clays such as the bentonites, kaolin, hectorite, smectites and saponites or mixtures thereof in combination with attapulgite.
Montmorillonite is the name of a group of clays with an expanding lattice which are members of the clay-mineral group. The montmorillonites contain aluminum silicates with some mont-morillonites having some of the aluminum replaced by magnesium.
The sulfurated lime composition of the present invention can be administered in various manners to achieve the desired effect. The amount of sulfurated lime solution in the composition will vary with the severity of the acne or oily skin condition and the mode of administration. Generally, the sulfurated lime solution comprises about 1-20% by weight of the total composition, preferably 2-10% weight of the total composition. The sorbent powders are
10015 3
employed in the amount of about 5-50% by weight of composition. The sorbent powder to be an effective deodorant for the sulfurated lime solution must contain at least about 2-9% by weight of a montmorillonite clay based on the weight of the total composition, and at least about 1.5% by weight of attapulgite based on the weight of the total composition. The topical formulation of the present invention may contain pharmaceutically acceptable surfactants, particularly those having a detergent action for microabrasion of the uppermost layer of the skin, i.e., horny layer, to provide a smooth feeling to the skin, soothing agents such as camphor, cooling agents such as menthol, dispersing agents, penetrants, perfumes, and a conservation agent such as butylated hydroxytoluene.
The addition of calcium carbonate to the composition has been found to be advantageous for maintaining the composition's i ■
alkalinity and color. Also, it is useful in providing a micro abrasive effect so as to remove the horny layer of the skin and leave a smooth feeling.
Talc may be added to the composition to improve the slip qualities of the composition on the skin.
An effective amount of the other acne-treating agents may be incorporated in the composition such as in an amount of up to 6% by weight of the composition. These additional active ingredients include salicylic acid, resorcinol and its derivatives, retinoic acid and its derivatives, sulfur, erythromycin, and the like. Aerosol preparations containing the sulfurated lime solution and the mixture of clays together with extenders in the form of a finely grouped powder may also be employed for topical administration. The aerosols may be packaged in a pressurized
. XO 01 53.
♦
aerosol container together with a gaseous or liquified propellant, for example, dichlorodifluoromethane,"dichlorodifluorcthanet carbon dioxide, nitrogen, or propane with the usual adjuvant such as a suspending agent and wetting agents as may be necessary or desirable. Although the present formulation may be applied directly to the site requiring treatment, it is preferably applied in the form of a face' mask so that during its application, the absorbing and adsorbing action of the sorbent powder on the face oils takes place and the sulfurated lime becomes more effective in the desired treatment of the skin condition.
The following examples are illustrative of formulations of compositions according to thisi invention.
EXAMPLE I
A composition for use as a face mask containing the following composition:
Sulfurated lime, solution (Vleminckx*s solution)
Colloidal aluminum magnesium silicate (Veegum®) (a montmorillonite type clay)
Attapulgite Sodium lauryl sulfate Butylated hydroxytoluene Purified water was prepared as follows:
Into a beaker containing 5 ml of sulfurated lime solution, 150 mg of sodium lauryl sulfate, 15 mg of butylated hydroxytoluene and 10 ml of purifed water was stirred in 750 mg of colloidal aluminum magenesium silicate and 250 mg of attapulgite until a uniform paste was formed. The composition contained essentially no sulfur odor and was suitable for forming a face mask in the treatment of acne.
ml 75 0 mg
250 mg 150 mg 15 mg q. s.
00153
EXAMPLE II
A composition for the treatment of acne and seborrheic conditions having the following:
Sulfurated lime solution 20 ml
Hectorite clay 1.5 g
Attapulgite 0.75 g t
Polyethylene glycol monostearate 0.50 g
Purified water q.s.
was prepared as follows:
Into a beaker containing 20 ml of sulfurated lime solution was added 1.5 g of Laponite®, a commercially available hectorite clay and 0.75 g of attapulgite. Purified water was then heated and mixed with polyethylene glycol monostearate until uniform. Then mixed and cooled to room temperature. This was then 15 added until a thick paste was formed that was spreadable by use of an applicator stick. V
EXAMPLE III '
A paste for a face mask for use in the treatment of severe acne and having an anti-seborrheic effect comprising:
Sulfurated lime solution 20 ml
Retinoic acid 12 mg
Sodium lauryl sulfate 0.5 g
Bentonite 2 g
Attapulgite 1 g
Purified water q.s.
was prepared as follows:
X0015 3
Into a beaker containing 20 mg of sulfurated lime solution was added with stirring 0.5 g of sodium lauryl sulfate, 12 mg of ■ retinoic acid* 1 g of attapulgite and 2 g of pulverized bentonite clay. Purified water was then added to the mixture until a paste 5 of a desired consistency was obtained. The resulting paste may then be applied directly to the site requiring treatment. A current of warm air may then be blown on the face until the mixture dries. The composition is maintained on the face for about 20 to about 30 minutes and then removed by washing with water. The treatment is 10 administered either every other day or daily until the condition treated is alleviated.
i
EXAMPLE IV
Ingredients %
Vleminckx's solution 6.00
Partially acetylated polyoxyethylene 2.00
lanolin ether (Laneth-10 acetate
Decyl oleate 0.60
Alcohol 7.00
Titanium dioxide 3.00
• Kaolin 15.00
Calcium Carbonate 2.30.
Attapulgite 3.50
Calcium silicate 2.00
Silica 0.225
EDTA 0.10 .
Paraben 0.20
Dioctyl sodium sulfosuccinate 0.16
Fragrance 0.10
Fatty alkanolamide 5.00
Sodium sulfate of an et-hoxylated fatty alcohol 5.00
Purified water q.s.
2 00153
The formulation was effective for the treatment of acne and oily skin conditions. Removal of the paste after drying by water washing gave a smooth feeling to the skin.
Comparison Experiment A
A sulfur-containing lotion was prepared utilizing a convention al formulation with the following ingredients:
\ Ingredients %
Sulfur (U.S.P.) i 5.00
Cellulose gum 0.45
Propylene glycol 3.00
Attapulgite 2.00
Iron oxide 1.20
Alcohol 20.00
Fragrance • 0.10
Fatty alkanolamide 2.00
Methyl paraben 0.15
Talc 7.00
Zinc oxide 7.00
Deionized water q.s.
Titanium Dioxide 4.00
Comparison Experiment B
A lotion was prepared utilizing the formula of Experiment A except that a sulfurated lime solution (Vleminckx's solution) was utilized in lieu of sulfur.
TABLE I
200153
Sample
1. Vleminckx's solution
2. Elemental sulfur
3. Paste of Experiment 4
4• Lotion of Experiment A
. Lotion of Experiment B
Odor
Cosmetic Effect
Poor (not suitable for use)
Objectionable Slightly pungent Poor (could be used)
Pleasant
Pleasant
Slightly Objectionable
Good
Good
Fair (not suitable for use)
It was noted that elemental sulfur by itself or in a conventional carrier could be utilized by patients without any ob-
I
jectionable odor being present. Use of a sulfurated lime solution by itself or in a conventional carrier such as those containing elemental sulfur still produced an objectionable odor which would prevent use on the face area. A formulation prepared according to Example 4 had a pleasant odor and could be utilized for skin care.
EXPERIMENT C
A. Mixutes of 6% sulfurated lime solution and the following clays were prepared with sufficient water to give paste-like consistencies:
1.
2.
3.
4.
Clay
Bentonite
Kaolin
Attapulgite
TABLE I
Test A (parts by wt.)
10 10
Calcium silicate
Odor
Pungent Pungent Pungent Pungent
Test B (parts by wt.)
.
" 20
Odor
Pungent Pungent Pungent Pungent
Claims (4)
1. A method for deodorizing cosmetic and therapeutic compositions having an objectionable odoriferous sulfur-containing compound which comprises incorporating in said composition an effective deodorizing amount of a pharmaceutically acceptable finely divided inorganic sorbent powder.
2. The method of Claim 1 wherein the composition comprises 5-50% by weight of said sorbent powder.
3. The method of Claim 1 or Claim 2 wherein said sorbent powder is a clay, pigment extender or mixtures thereof.
4. The method of any one of Claims 1 to 3 wherein said sorbent powder is a clay selected from the group consisting of bentonite, hectorite, smectite, attapulgite, fuller's earth and montmorillonite clays. said sorbent powder is colloidal aluminum magnesium silicate, kaolin, talc or calcium carbonate. ion comprising an effective amount of a sulfurated lime solution and 5-50% by weight of a carrier comprising a pharmaceutically acceptable clay, pigment extender or mixtures thereof.
7. The composition of Claim 6 wherein said sulfurated lime solution comprises 1-10% by weight of said composition.
8. The composition of Claim 6 or 7 including a compound selected from the group consisting of salicylic acid, resorcinol, retinoic acid and derivatives thereof.
5. The method of any one of Claims 1 to 3 wherein
6. A therapeutic composition for topical administratis. The method of any one of Claims 1 to 5 substantially as herein described.
10. The composition of any one of Claims 6 to 8 substantially as herein described. BjM^te/Their Authorised Agents, 12 A. j. PARK & SON
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ19857582 | 1982-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ200153A true NZ200153A (en) | 1985-04-30 |
Family
ID=19919765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ200153A NZ200153A (en) | 1982-03-29 | 1982-03-29 | Treating acne and oily skin by topically administering a composition sulphurated lime solution and a mixture of clays |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ200153A (en) |
-
1982
- 1982-03-29 NZ NZ200153A patent/NZ200153A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0081492B1 (en) | Method and composition for treating acne | |
| AU615279B2 (en) | Skin moisturizing composition and method of preparing same | |
| US6689339B1 (en) | Viscous compositions containing carbon dioxide | |
| US4350681A (en) | Stabilized benzoyl peroxide compositions | |
| US4376115A (en) | Method and composition for treating teeth and method for preparing same | |
| US4411885A (en) | Vitamin E oil based dentifrice | |
| US5122533A (en) | Topical pharmaceutical compositions | |
| JPH07196497A (en) | Pharmaceutical composition suitable for inhibiting acne or seborrhea | |
| AU745041B2 (en) | Topical composition | |
| JP7548937B2 (en) | Antiperspirant and deodorant compositions | |
| JP2002515413A (en) | Deodorant | |
| JP2899885B2 (en) | Deodorants | |
| NZ200153A (en) | Treating acne and oily skin by topically administering a composition sulphurated lime solution and a mixture of clays | |
| US6007827A (en) | Method of depigmenting or bleaching mammalian skin using L-2-oxothiazolidine-4-carboxylic acid | |
| JP3271405B2 (en) | Deodorant cosmetics | |
| US6063389A (en) | Composition for depigmenting or bleaching mammalian skin containing L-2-oxothiazolidine-4-carboxylic acid and a polyol | |
| JP2865380B2 (en) | Antibacterial cosmetic | |
| JP2549148B2 (en) | Cleaning cosmetics | |
| US4080465A (en) | Topical application of cis or trans 3,4-thiolannediol to reduce or substantially eliminate the greasy appearance of the skin | |
| JPS6343665A (en) | Deodorant | |
| JPH03846B2 (en) | ||
| HK1079111A (en) | Cosmetic use of viscous compositions containing carbon dioxide | |
| JP2000016928A (en) | Antiperspirant |